As to your question, again it sounds interesting and quite positive when you throw out a simple idea: wouldn't it be nice if we...? But in reality, our greatest concern is that we would be moving to the lowest common denominator.
As to your earlier point, I find it difficult to imagine how you're going to create a national formulary, possibly driven by a strategy very oriented to cost containment and that at a certain level will be making decisions about which drugs are available for which patients. Ultimately it will be the provincial level that will be paying for the consequences of those decisions, because I passionately believe that in fact good utilization of innovative medicines not only saves and improves lives but also saves money within the health care system.
So the concern is that the current movement would be towards a reduction of access versus an increase in access.